Skip to main content
Earnings Labs
Outlook Therapeutics, Inc. logo

Outlook Therapeutics, Inc. (OTLK)

NASDAQ·Healthcare·Biotechnology

$1.68

+7.01%

Mkt Cap $11.72M

Analyst Ratings

Buy

3

Hold

5

Sell

0

Price Target (2 analysts)

$1.00

Range $1.00$1.00

Implied Upside

-40.5%

Consensus $1.00 vs current $1.68